Do mornings make cancer immunotherapy more effective? Study: Maybe
Stat News • 2/2/2026
Summary
A clinical trial has provided evidence for a phenomenon observed by oncologists, where patients receiving cancer immunotherapy in the morning tend to have better outcomes than those receiving infusions in the afternoon. This finding suggests that the timing of treatment may influence its effectiveness.
Advertisement
Lindy Score Breakdown (V4.2)
27d
Age
1
Sources
from cluster
646
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^646/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^646/48 = 0.000089) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 26 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Listen: FDA turmoil, election intrigue, AI, and more
Stat News • 2 days ago
STAT+: Up and down the ladder: The latest comings and goings
Stat News • 1 day ago
STAT+: What stands between brain implants and FDA approval?
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about FDA and a ‘smear campaign,’ Cigna buying a large pharmacy, and more
Stat News • 2 days ago
Kennedy announces new vaccine advisory committee members after meeting rescheduled
Stat News • 1 day ago
STAT+: The nation’s MAHA mom lands in Congress, with some uncomfortable questions
Stat News • 2 days ago
Henrietta Lacks’ estate settles with Novartis over the ‘stolen cells’ that advanced science
Stat News • 1 day ago
Kansas’ new ID law could have health consequences for trans people
Stat News • 1 day ago
Opinion: Former surgeon general: The Senate must not approve someone who can’t practice medicine as the nation’s top doctor
Stat News • 2 days ago
Opinion: I’m a rare disease mom, and I finally have new hope for my son’s future
Stat News • 2 days ago